These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16772986)

  • 1. Late erythema after photodynamic therapy to the face.
    Misra A; Maybury K; Eltigani TA
    Plast Reconstr Surg; 2006 Jun; 117(7):2522-3. PubMed ID: 16772986
    [No Abstract]   [Full Text] [Related]  

  • 2. Is the pain of topical photodynamic therapy with methyl aminolevulinate any different from that with 5-aminolaevulinic acid?
    Ibbotson SH; Valentine R; Hearn R
    Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):272-3. PubMed ID: 22971196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid progression of a basal cell carcinoma after photodynamic therapy.
    Karen JK; Hale EK
    Dermatol Surg; 2010 Aug; 36(8):1328-31. PubMed ID: 20584044
    [No Abstract]   [Full Text] [Related]  

  • 4. Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma.
    Vinciullo C; Elliott T; Francis D; Gebauer K; Spelman L; Nguyen R; Weightman W; Sheridan A; Reid C; Czarnecki D; Murrell D
    Br J Dermatol; 2005 Apr; 152(4):765-72. PubMed ID: 15840111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy of superficial basal cell carcinoma by instillation of aminolevulinic acid and irradiation with visible light.
    Fink-Puches R; Wolf P; Kerl H
    Arch Dermatol; 1997 Dec; 133(12):1494-5. PubMed ID: 9420532
    [No Abstract]   [Full Text] [Related]  

  • 6. Ameluz for actinic keratoses.
    Med Lett Drugs Ther; 2016 Dec; 58(1509):155-156. PubMed ID: 27906150
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of basal cell carcinoma with topical methylaminolaevulinate photodynamic therapy in an organ-transplant recipient.
    Perrett CM; Tan SK; Cerio R; Goldsmith PC; McGregor JM; Proby CM; Harwood CA
    Clin Exp Dermatol; 2006 Jan; 31(1):146-7. PubMed ID: 16309518
    [No Abstract]   [Full Text] [Related]  

  • 8. Recurrence rate of basal cell carcinoma after topical aminolevulinic acid-based photodynamic therapy.
    Naidenov N; Dencheva R; Tsankov N
    Acta Dermatovenerol Croat; 2004; 12(3):157-61. PubMed ID: 15369639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting pain and effect of oral analgesia in topical photodynamic therapy.
    Hambly RA; Mansoor N; Quinlan C; Shah Z; Lenane P; Ralph N; Moloney FJ
    Photodermatol Photoimmunol Photomed; 2017 May; 33(3):176-179. PubMed ID: 28196277
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute phototoxicity with urticarial features during topical 5-aminolaevulinic acid photodynamic therapy.
    Kerr AC; Ferguson J; Ibbotson SH
    Clin Exp Dermatol; 2007 Mar; 32(2):201-2. PubMed ID: 17244343
    [No Abstract]   [Full Text] [Related]  

  • 11. Urticaria after methyl aminolevulinate photodynamic therapy in a patient with nevoid basal cell carcinoma syndrome.
    Wolfe CM; Green WH; Hatfield HK; Cognetta AB
    J Drugs Dermatol; 2012 Nov; 11(11):1364-5. PubMed ID: 23135091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical photodynamic therapy in clinical dermatology.
    Kormeili T; Yamauchi PS; Lowe NJ
    Br J Dermatol; 2004 Jun; 150(6):1061-9. PubMed ID: 15214890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of patients with basal cell carcinoma after successful treatment with intralesional photodynamic therapy.
    Suárez Valladares MJ; Pérez Paredes MG; González Sixto B; Rodríguez Prieto MÁ
    J Am Acad Dermatol; 2016 Dec; 75(6):e247. PubMed ID: 27846979
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety of Novel Amino-5-laevulinate Photosensitizer Precursors in Photodynamic Therapy for Healthy Human Skin.
    Neittaanmäki-Perttu N; Neittaanmäki E; Pölönen I; Snellman E; Grönroos M
    Acta Derm Venereol; 2016 Jan; 96(1):108-10. PubMed ID: 25940811
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors influencing pain and efficacy of topical photodynamic therapy: a retrospective study.
    Lydon E; Dawe RS; Ibbotson SH
    Br J Dermatol; 2019 Jan; 180(1):205-206. PubMed ID: 30216404
    [No Abstract]   [Full Text] [Related]  

  • 16. New proposal for the treatment of nodular basal cell carcinoma with intralesional 5-aminolevulinic acid.
    Cappugi P; Mavilia L; Campolmi P; Reali EF; Mori M; Rossi R
    J Chemother; 2004 Oct; 16(5):491-3. PubMed ID: 15565918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminolevulinic acid (Levulan) in photodynamic therapy of actinic keratoses.
    Lang K; Schulte KW; Ruzicka T; Fritsch C
    Skin Therapy Lett; 2001 Sep; 6(10):1-2, 5. PubMed ID: 11685275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy update 2007.
    Gold MH
    J Drugs Dermatol; 2007 Nov; 6(11):1131-7. PubMed ID: 18038501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodular basal cell carcinoma: when in doubt, cut it out.
    Brownell I
    J Drugs Dermatol; 2007 Dec; 6(12):1245-6. PubMed ID: 18189068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral facial palsy after topical photodynamic therapy for facial actinic keratoses.
    Gemigniani F; Bodet D; González-Llavona B; García-Patos V
    J Am Acad Dermatol; 2014 Sep; 71(3):e90-2. PubMed ID: 25128142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.